Craig R. Skenes
Corporate Officer/Principal presso AERIE PHARMACEUTICALS, INC.
Posizioni attive di Craig R. Skenes
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Corporate Officer/Principal | 16/06/2014 | - |
Storia della carriera di Craig R. Skenes
Formazione di Craig R. Skenes
| The California State University | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
Posizioni
| Corporate Officer/Principal | 1 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
- Borsa valori
- Insiders
- Craig R. Skenes
- Esperienza
